University of California, Irvine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma

    Clinical Cancer Research, Vol. 28, Núm. 16, pp. 3537-3545